Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Melanoma
  Free Subscription

Articles published in
Proc Natl Acad Sci U S A
    July 2026
  1. SHETTIGAR M, Mouliere S, Isenegger L, DeVine AL, et al
    Oncogenic Galpha signaling requires AP-3-dependent recruitment to the endolysosomal compartment.
    Proc Natl Acad Sci U S A. 2026;123:e2615774123.
    >> Share

    June 2026
  2. ZHANG R, Wang J, Wu S, Shen X, et al
    Programmable DNA hydrogels for dual-mode PD-L1 suppression via polyvalent LYTAC mimics and transcriptional silencing.
    Proc Natl Acad Sci U S A. 2026;123:e2602147123.
    >> Share

    May 2026
  3. YANG X, Qiao X, Schmidt S, Eklund EA, et al
    ICMT supports BRAF(V600E)-driven tumor growth by membrane targeting of the CAAX protein INPP5E.
    Proc Natl Acad Sci U S A. 2026;123:e2601795123.
    >> Share

    February 2026
  4. BAIRD MA, Jewett CE, Malide DA, Kratz L, et al
    Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion.
    Proc Natl Acad Sci U S A. 2026;123:e2513031123.
    >> Share

    December 2025

  5. Correction for AbuHammad et al., Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2025;122:e2533731122.
    >> Share

  6. FINCK AV, Wang Z, Gonzales D, Wellhausen N, et al
    Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy.
    Proc Natl Acad Sci U S A. 2025;122:e2518996122.
    >> Share

    November 2025
  7. SONG K, Nguyen DC, Wang Y, Jokonya S, et al
    Peptide vaccine formulations with structurally distinct STING agonist drugamers induce discrete, efficacious antitumor responses.
    Proc Natl Acad Sci U S A. 2025;122:e2409978122.
    >> Share

    July 2025
  8. BARNET MB, Jackson KJL, Masle-Farquhar E, Russell A, et al
    Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
    Proc Natl Acad Sci U S A. 2025;122:e2314258122.
    >> Share

    June 2025
  9. SHARMA B, Aswin K, Jain T, Nasreen A, et al
    Mgat4b-mediated selective N-glycosylation regulates melanocyte development and melanoma progression.
    Proc Natl Acad Sci U S A. 2025;122:e2423831122.
    >> Share

    March 2025
  10. NAZERAI L, Tsiavou C, Vardouli L, Schmiegelow K, et al
    Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.
    Proc Natl Acad Sci U S A. 2025;122:e2423246122.
    >> Share

    October 2024
  11. VALCIKOVA B, Vadovicova N, Smolkova K, Zacpalova M, et al
    eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations.
    Proc Natl Acad Sci U S A. 2024;121:e2321305121.
    >> Share

    August 2024
  12. MUKOHARA F, Iwata K, Ishino T, Inozume T, et al
    Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.
    Proc Natl Acad Sci U S A. 2024;121:e2320189121.
    >> Share

    June 2024
  13. DI LEO L, Pagliuca C, Kishk A, Rizza S, et al
    AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2400566121.
    >> Share

    May 2024

  14. Correction for Ichimura et al., Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2408646121.
    >> Share

    April 2024
  15. ICHIMURA Y, Konishi R, Shobo M, Tanaka R, et al
    Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2313070121.
    >> Share

  16. PIRES L, Khattak S, Pratavieira S, Calcada C, et al
    Femtosecond pulsed laser photodynamic therapy activates melanin and eradicates malignant melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2316303121.
    >> Share

  17. LEE KW, Ryu KJ, Kim M, Lim S, et al
    RCHY1 and OPTN are required for melanophagy, selective autophagy of melanosomes.
    Proc Natl Acad Sci U S A. 2024;121:e2318039121.
    >> Share

    January 2024
  18. BANUELOS A, Zhang A, Berouti H, Baez M, et al
    CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance.
    Proc Natl Acad Sci U S A. 2024;121:e2318534121.
    >> Share

  19. DUAN M, Song S, Wasserman H, Lee PH, et al
    High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2310854121.
    >> Share

    December 2023
  20. CHENG Q, Farbiak L, Vaidya A, Guerrero E, et al
    In situ production and secretion of proteins endow therapeutic benefit against psoriasiform dermatitis and melanoma.
    Proc Natl Acad Sci U S A. 2023;120:e2313009120.
    >> Share

    November 2023
  21. GUO D, Jurek R, Beaumont KA, Sharp DS, et al
    Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis.
    Proc Natl Acad Sci U S A. 2023;120:e2303978120.
    >> Share

  22. MAJI S, Pradhan AK, Kumar A, Bhoopathi P, et al
    MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
    Proc Natl Acad Sci U S A. 2023;120:e2307094120.
    >> Share

    September 2023
  23. ZHANG X, Shi X, Zhang D, Gong X, et al
    Compression drives diverse transcriptomic and phenotypic adaptations in melanoma.
    Proc Natl Acad Sci U S A. 2023;120:e2220062120.
    >> Share

    August 2023
  24. CENTOFANTI E, Wang C, Iyer S, Krichevsky O, et al
    The spread of interferon-gamma in melanomas is highly spatially confined, driving nongenetic variability in tumor cells.
    Proc Natl Acad Sci U S A. 2023;120:e2304190120.
    >> Share

    July 2023
  25. MICEVIC G, Daniels A, Flem-Karlsen K, Park K, et al
    IL-7R licenses a population of epigenetically poised memory CD8(+) T cells with superior antitumor efficacy that are critical for melanoma memory.
    Proc Natl Acad Sci U S A. 2023;120:e2304319120.
    >> Share

    March 2023
  26. ZHOU J, Ma X, He X, Chen B, et al
    Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target.
    Proc Natl Acad Sci U S A. 2023;120:e2215732120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016